Skip to main content
. 2021 Dec 30;138(26):2810–2827. doi: 10.1182/blood.2020010146

Table 2.

Baseline patient characteristics by MRD status for patients randomly assigned to FCR and tested successfully for MRD

Variable/category MRD MRD+ Total P
Patients, n 83 39 122
Age
 Mean (SD) 56.4 (7.3) 56.6 (6.7) 56.4 (7.1) .895
 Median (Q1, Q3) 57.0 (51.0, 62.0) 57.0 (53.0, 60.0) 57.0 (52.0, 61.8)
 [Min, max] [32.0, 69.0] [28.0, 68.0] [28.0, 69.0]
 Freq. of missing 0 0 0
Age, category
 <60 51 (61.4) 24 (61.5) 75 (61.5) 1.000
 ≥60 32 (38.6) 15 (38.5) 47 (38.5)
 Unknown/missing 0 0 0
Sex
 Female 30 (36.1) 10 (25.6) 40 (32.8) .304
 Male 53 (63.9) 29 (74.4) 82 (67.2)
 Unknown/missing 0 0 0
RAI stage
 Low, 0 8 (9.6) 1 (2.6) 9 (7.4) .170
 Intermediate, I-II 47 (56.6) 19 (48.7) 66 (54.1)
 High, III-IV 28 (33.7) 19 (48.7) 47 (38.5)
 Unknown/missing 0 0 0
ECOG performance status
 0 50 (60.2) 20 (51.3) 70 (57.4) .593
 1 32 (38.6) 18 (46.2) 50 (41.0)
 2 1 (1.2) 1 (2.6) 2 (1.6)
 Unknown/missing 0 0 0
Hemoglobin, g/dL
 Mean (SD) 12.6 (2.0) 11.6 (1.8) 12.2 (2.0) .004
 Median (Q1, Q3) 12.8 (11.5, 14.1) 11.9 (10.6, 12.6) 12.5 (11.2, 13.8)
 [Min, max] [5.5, 17.6] [6.9, 15.9] [5.5, 17.6]
 Freq. of missing 1 1 2
Platelets, 103/μL
 Mean (SD) 163.9 (79.7) 151.6 (84.1) 159.9 (81.0) .339
 Median (Q1, Q3) 151.0 (105.0, 204.0) 130.0 (98.5, 183.0) 144.5 (103.5, 191.5)
 [Min, max] [43.0, 485.0] [13.0, 433.0] [13.0, 485.0]
 Freq. of missing 0 0 0
WBC, 103/μL
 Mean (SD) 92.9 (95.8) 129.9 (117.4) 104.7 (104.1) .017
 Median (Q1, Q3) 53.5 (18.8, 151.5) 95.4 (43.6, 165.6) 72.4 (26.4, 160.8)
 [Min, max] [3.1, 434.1] [11.8, 638.9] [3.1, 638.9]
 Freq. of missing 0 0 0
β2-Microglobulin, mg/L
 Mean (SD) 3.8 (1.8) 4.4 (2.1) 4.0 (1.9) .065
 Median (Q1, Q3) 3.4 (2.5, 4.5) 3.8 (3.1, 5.3) 3.4 (2.7, 4.8)
 [Min, max] [1.3, 12.2] [2.0, 11.1] [1.3, 12.2]
 Freq. of missing 0 0 0
β2-Microglobulin, category *
 Elevated 38 (45.8) 21 (53.8) 59 (48.4) .442
 Normal 45 (54.2) 18 (46.2) 63 (51.6)
 Unknown/missing 0 0 0
Serum creatinine, mg/dL
 Mean (SD) 96.0 (5.6) 96.1 (6.1) 96.0 (5.7) .943
 Median (Q1, Q3) 95.1 (91.9, 99.6) 94.5 (92.5, 97.4) 94.7 (92.5, 98.5)
 [Min, max] [86.8, 117.1] [87.5, 117.9] [86.8, 117.9]
 Freq. of missing 0 0 0
Coombs test
 Negative 75 (92.6) 38 (97.4) 113 (94.2) .425
 Positive 6 (7.4) 1 (2.6) 7 (5.8)
 Unknown/missing 2 0 2
Splenomegaly
 No 52 (62.7) 18 (46.2) 70 (57.4) .116
 Yes 31 (37.3) 21 (53.8) 52 (42.6)
 Unknown/missing 0 0 0
Lymphadenopathy
 No 31 (37.3) 9 (23.1) 40 (32.8) .149
 Yes 52 (62.7) 30 (76.9) 82 (67.2)
 Unknown/missing 0 0 0
Del(11q22.3)
 Abnormal 15 (18.1) 11 (28.2) 26 (21.3) .238
 Normal 68 (81.9) 28 (71.8) 96 (78.7)
 Unknown/missing 0 0 0
Dohner classification
 Del(17p) 0 (0.0) 0 (0.0) 0 (0.0) .226
 Del(11q22) 15 (18.1) 11 (28.2) 26 (21.3)
 Trisomy 12 15 (18.1) 9 (23.1) 24 (19.7)
 Normal 19 (22.9) 3 (7.7) 22 (18.0)
 Del(13q) 28 (33.7) 12 (30.8) 40 (32.8)
 Other 6 (7.2) 4 (10.3) 10 (8.2)
 Unknown/missing 0 0 0
IGHV
 Mutated 34 (49.3) 9 (25.7) 43 (41.3) .034
 Unmutated 35 (50.7) 26 (74.3) 61 (58.7)
 Unknown/missing 14 4 18
Time up and go, s §
 Mean (SD) 8.5 (2.1) 9.8 (3.3) 8.9 (2.6) .053
 Median (Q1, Q3) 8.0 (7.0, 10.0) 9.0 (8.0, 10.0) 9.0 (7.2, 10.0)
 [Min, max] [2.0, 16.0] [5.0, 20.0] [2.0, 20.0]
 Freq. of missing 0 0 0
CIRS
 Mean (SD) 2.2 (1.9) 2.5 (2.0) 2.3 (2.0) .360
 Median (Q1, Q3) 2.0 (0.0, 3.5) 2.0 (1.0, 4.0) 2.0 (1.0, 4.0)
 [Min, max] [0.0, 7.0] [0.0, 7.0] [0.0, 7.0]
 Freq. of missing 8 9 17
% CD19+CD5+cells
 Mean (SD) 69.5 (28.8) 83.1 (17.8) 73.8 (26.5) .012
 Median (Q1, Q3) 79.3 (53.0, 93.6) 90.3 (72.6, 96.3) 85.1 (61.4, 94.5)
 [Min, max] [3.8, 99.2] [33.6, 99.1] [3.8, 99.2]
 Freq. of missing 2 1 3
% CD38+ cells
 Mean (SD) 35.1 (36.8) 31.3 (34.5) 33.9 (36.0) .372
 Median (Q1, Q3) 15.6 (2.0, 70.9) 19.8 (1.0, 55.7) 17.9 (1.5, 65.9)
 [Min, max] [0.1, 99.7] [0.2, 95.3] [0.1, 99.7]
 Freq. of missing 2 1 3
%CD38+ cells, category
 High (>30%) 36 (44.4) 15 (39.5) 51 (42.9) .693
 Low (≤30%) 45 (55.6) 23 (60.5) 68 (57.1)
 Unknown/missing 2 1 3
% CD49d+ cells
 Mean (SD) 46.1 (44.3) 25.4 (36.9) 39.5 (43.0) .009
 Median (Q1, Q3) 22.4 (1.5, 98.0) 7.8 (0.4, 35.8) 13.9 (1.0, 97.0)
 [Min, max] [0.2, 100.0] [0.1, 100.0] [0.1, 100.0]
 Freq. of missing 2 1 3
%CD49d+ cells, category
 High (>30%) 40 (49.4) 11 (28.9) 51 (42.9) .047
 Low (≤30%) 41 (50.6) 27 (71.1) 68 (57.1)
 Unknown/missing 2 1 3
% ZAP-70+ cells
 Mean (SD) 19.2 (19.7) 19.7 (24.0) 19.3 (21.1) .713
 Median (Q1, Q3) 9.6 (3.9, 31.6) 12.9 (2.6, 23.7) 9.6 (3.5, 30.6)
 [Min, max] [0.1, 67.1] [0.2, 82.7] [0.1, 82.7]
 Freq. of missing 2 1 3
%ZAP-70+ cells, category
 High (>20%) 30 (37.0) 12 (31.6) 42 (35.3) .682
 Low (≤20%) 51 (63.0) 26 (68.4) 77 (64.7)
 Unknown/missing 2 1 3
TK (U/L)
 Mean (SD) 24.5 (28.6) 43.2 (87.3) 30.5 (55.0) .091
 Median (Q1, Q3) 15.0 (7.1, 34.7) 26.3 (11.1, 42.5) 17.7 (8.4, 37.4)
 [Min, max] [0.0, 199.0] [0.0, 547.0] [0.0, 547.0]
 Freq. of missing 2 1 3

MRD undetectable indicates that the patient had undetectable MRD at least once. Patients without MRD data are not included.

*

Elevated defined as values >3.5 mg/L.

Direct anti-globulin test.

Based on Döhner et al.34

§

Timed up and go test.35,36